African Vaccinology Network (AfVANET) Scientific Workshop
Nairobi, Kenya 19-20 March 2019
The Network objectives:
- To bring together all stakeholders in vaccinology and related sciences in Africa
- To identify and prioritize vaccine gaps in Africa
- To promote vaccine research and development in Africa
- To promote sound ethics, biosafety and biosecurity in vaccine research in Africa
- To introduce AfVANET to the African scientific community and vaccine stakeholders
- To discuss the challenges and opportunities in vaccine development in Africa including:
- Current vaccine needs in Africa.
- Vaccine R&D in Africa – Networks and Institutions.
3. To support African women and early career researchers in vaccine research.
4. To promote vaccine research and development in Africa.
Please direct all enquiries to Prof Mustapha Oumouna at email@example.com.
Day 1 - March 19th
Prof Mustapha Oumouna: African Vaccinology Network (AfVANET): Background, information, scope and purpose of AfVANET.
Session 1:Animal and Human Vaccines in Africa: the need, availability and opportunities for innovation.
Chair: Prof Christine Maritz-Olivier
09:30-09:50 Dr. Yakhya Dieye (AfVANET) North African Region.
09:50-10:10 Dr. David Lazarus(AfVANET) Southern African Region.
10:10-10:30 Dr. Mamo Gazahegne (AfVANET) East African Region.
10:30-10:50 Dr. Dinga Gerome (AfVANET) Central African Region.
10:50-11:10 Dr Kwabena Duedu(AfVANET) West African Region.
11:10-1130: Coffee break
Session 2: The Vaccine Supply Chain: Yesterday, Today and Tomorrow. The Importance of Networks in Vaccine Research and R&D in Africa
Chair: Dr Vish Nene
11:30-12:00 Dr Tim Connelley (IVVN): The IVVN – A Role in Facilitating Research to Advance Veterinary Vaccine Development.
12:00-12:25 Dr Jeremy Salt (Galvmed): GALVmed: Vaccine Development Partnerships in sub-Saharan Africa.
12:30-13:00 Dr Victor Mbao (IDRC): Livestock Vaccine Innovation Fund’s objectives, current and planned activities.
Session 3: The Role of African and International Institutions in the Fight Against Infectious Diseases: Vaccine Design and Development
Chair person: Dr Tim Connelley
14:00-14:30 Dr Vish Nene, ILRI Nairobi, Kenya, ILVAC, ILRI’s Investment in Vaccine Research.
14:30-14:55 Pr Christine Maritz-Olivier, University of Pretoria South Africa: Suppression of Bovine Immunity by Rhipicephalusmicroplus- Lessons for Future Vaccine Development.
14:55-15:20 Dr Denise Doolan (ISV), Incorporating Technological Advances into Vaccine Development for Infectious Diseases.
15:20-15:45 Dr Stefano Messori (STAR-IDAZ IRC), Improving research coordination and collaboration on animal health in Africa: the role of the STAR-IDAZ IRC.
15:45-16:10 Dr Jennifer Maroa (The African Academy of Sciences), Building an Open Database of African Clinical Trials Capacities and Sites.
16:10-16:40: Coffee break
16:40-17:05 Dr David Shamaki, Vom, Nigeria:Vaccine Research and Development at the National Veterinary Research Institute Vom, Nigeria”.
17:05-17:30 Pr George Warimwe, Kemri-Welcome Trust : The KEMRI-Welcome Trust Laboratories and Program.
Day 2 - 20th March
Session 4: AfVANET Women in R&D against infectious diseases
Chair:Prof Denise Doolan
09:00-09:20 Dr Afolayan Funmilayo, Nigeria: Towards the discovery of adjuvantsandimmunomodulators for infectious diseases from botanicals.
09:20-09:40 Dr Nontobeko Thema, South Africa:Identification and characterisation of Ehrlichiaruminantium vaccine candidate epitopes
09:40-10:00 Dr Maroua Bettaieb, Tunisia: Vaccine approach in poultry breeding : news and critical reading.
10:00-10:30 Coffee breack
Session 5 :Young African Voices
Chair: Dr Yakhya Dieye
10:30-10:50 Dr. Akinbobola Jones (Nigeria): ‘T. bruceigambiense in food animals – a possibility of vaccines for humans?’
10:50-11:10 Dr Elisa Daniel Mwega, TanzaniaPersistence and genetic diversity of Theileriaparva in cattle vaccinated against East Coast Fever inTanzania.
11:10-11:30 Dr Abraham Ali Mohammed, Ethiopia: Study on MERS-Coronavirus in Humans and Dromedary Camels in Amibara District of Afar National Regional state.
11:30-11:50 Mr Moussa Dia, Senegal: Toward the development of a West Nile Virus live vaccine strain: pre-exposure to benign lineage 8 virus protects mice against lethal challenge with virulent lineages.
11:50-12:10 Dr TshifhiwaNefefe, South Africa: Innate immune transcriptomic evaluation of PBMC isolated from sheep after infection with E. ruminantium Welgevonden strain.
Session 6: Infectious Diseases in Africa:Vaccine Research and Development
Chair: Dr Jeremy Salt
13:10-13:40 Dr Ignacio Moriyon, Spain:Current Brucellosis Vaccines: Their Use and Drawbacks and the way forward.
13:40-14:10 Dr Denise Doolan, ISV: Malaria:An overview of vaccine trial efforts in Africa.
14:10-14:40 Dr James Tuju, Kemri Welcome Trust: KILChip1.0: A novel Plasmodium falciparummerozoite protein microarray to facilitate malaria vaccine candidate prioritization
General debate and recommendations